Three helpful upcoming webinars | THE "NEW" PROSTATE CANCER INFOLINK

Three helpful upcoming webinars | THE "NEW" PROSTATE CANCER INFOLINK

prostatecancerinfolink.net

Three helpful upcoming webinars

3 minutes

Three upcoming webinars deal with (a) the diagnosis and work-up of clinically significant forms of localized prostate cancer; (b) handling anxiety and related issues for men on active surveillance (AS); and (c) whether AS is appropriate for African Americans and others of African ethnicity. See below for details.

On Wednesday, June 30, at 7:00 to 8:30 pm Eastern, the Cancer Support Community and Prostate Cancer International will be presenting a webinar on the diagnosis and work-up of men with clinically significant forms of prostate cancer (e.g., Gleason 4 + 3 = 7 or higher or other factors suggesting clinically significant disease). The featured speaker will be Prof. Eric Klein, MD, of the Cleveland Clinic. He will be addressing current and potential new ways to properly identify such patients among the previously undiagnosed and among men progressing on active surveillance.

You will be able to take advantage of this educational webinar in three ways:

On Saturday, June 26, at 12:00 (i.e., noon) to 1:30 pm Eastern, Active Surveillance Patients International is presenting a webinar on mood and anxiety issues and how they may impact decisions about starting and staying on active surveillance for relatively favorable risk form of localized prostate cancer. The featured speaker will be Alan J. Hsu, MD, a board-certified psychiatrist who works at Moores Cancer Center, UC San Diego Health, in San Diego.

To register for this webinar, please click here.

Then on Tuesday, June 29, at 8:00 p.m. Eastern, AnCan (and partner organizations) is kicking off a series of webinars focused on active surveillance at 8 p.m. ET June 29 with a program entitled “Is Active Surveillance Safe for Black Men?” The featured speakers for this program will be Anthony Henry, a Black man from Toronto who has been on AS for 5 years and is First Vice President of the Walnut Foundation; Willie Underwood III, MD, a high-profile Black urologist who opted for surgery; and Brandon Mahal, MD, a radiation oncologist and researcher on health equity issues and AS at the University of Miami.

To register for this webinar, please click here.

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: , , |

 

Comments

Post a Comment

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Image
Vanquish® Water Vapor Ablation System, Francis Medical Steams Out Prostate Cancer The Vanquish® Water Vapor Ablation System, developed by Francis Medical, Inc. , represents an innovative approach to treating prostate cancer using water vapor (steam) to ablate cancerous tissue. This minimally invasive technique aims to target and destroy prostate cancer cells while minimizing damage to surrounding healthy tissue, potentially reducing common side effects associated with traditional treatments like surgery and radiation, Mechanism of Action:  The Vanquish system utilizes the thermal energy stored in sterile water vapor to ablate cancerous prostate tissue. During the procedure, a catheter is inserted through the urethra into the prostate, delivering water vapor directly to the targeted tissue. As the vapor condenses back into liquid, it releases stored thermal energy, effectively destroying the cancerous cells. This method is designed to respect the prostate's natural boundaries, ...
Read more

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily

Image
Summary Sanjay S. Timilsina , currently Lead Scientist, StataDx, a spinoff from Wyss Institute, former Postdoctoral Fellow at Harvard Medical School and the Wyss Institute at Harvard University, PhD from UTEP Department of Chemistry & Biochemistry, and XiuJun Li full Professor in the Department of Chemistry and Biochemistry and of Forensic Science, & Environmental Science and Engineering, at the University of Texas at El Paso (UTEP) have developed a new portable device for cancer detection that offers several advantages over traditional methods: Key Features: - Low cost (a few dollars per device, <8 cents per assay) - Provides results in about 1 hour (vs. 12-16 hours for traditional methods) - Approximately 10 times more sensitive than traditional methods - Portable and doesn't require specialized instruments - Can detect both CEA colorectal and PSA prostate cancer biomarkers - Uses a "paper-in-polymer-pond" structure to analyze blood samples How it works: - U...
Read more

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News foxnews.com Associated Press For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. Advances in treatment mean millions of people are surviving for years with incurable cancers. Jill Feldman, 54, of Deerfield, Illinois, has lived 15 years with lung cancer , thanks to that progress. Her parents both died of lung cancer months after their diagnoses. But her cancer drug causes joint pain, fatigue and mouth sores that m...
Read more